Ishibashi M, Yamaji T, Takaku F, Teramoto A, Fukushima T
J Clin Endocrinol Metab. 1987 Jun;64(6):1187-93. doi: 10.1210/jcem-64-6-1187.
Serum glycoprotein hormone alpha-subunit levels were determined in 165 patients with pituitary adenomas. Elevated serum alpha-subunit levels were found in 17 patients (acromegaly, 5 of 58; prolactinoma, 6 of 56; nonfunctioning adenoma, 5 of 32; and ACTH-producing adenoma, 1 of 19), most of whom had normal serum TSH and gonadotropin levels. When TRH (0.5 mg) was injected iv in the 6 prolactinoma patients with elevated serum alpha-subunit levels, serum PRL and alpha-subunit levels increased in only 1 patient. Four acromegalic patients with high serum alpha-subunit levels received TRH; serum GH and alpha-subunit increased in 1 patient and did not change in 2, and only serum GH increased in the remaining patient. Oral administration of bromocriptine (5 mg), on the other hand, consistently decreased serum alpha-subunit and PRL levels in 2 patients with prolactinoma and alpha-subunit and GH levels in 1 acromegalic patient. When serum from 3 patients was subjected to Sephadex G-100 gel filtration, immunoreactive alpha-subunit eluted in a single peak, which emerged in fractions corresponding to [125I]TSH alpha. Concanavalin A (Con A) affinity chromatography revealed that the major portion of immunoreactive alpha-subunit was retained to Con A. A pituitary adenoma removed at surgery from a patient with acromegaly was studied in monolayer cell culture. Secretion of both alpha-subunit and GH from cultured adenoma cells was stimulated by TRH and suppressed by dopamine in a dose-dependent manner. Immunohistochemistry of the pituitary adenomas removed from patients with prolactinoma and acromegaly who had high serum alpha-subunit levels demonstrated alpha-subunit-containing cells as well as PRL- or GH-containing cells. These results suggest that elaboration of glycoprotein hormone alpha-subunit occurs without concurrent production of glycoprotein hormones in a substantial number of patients with pituitary adenomas and that alpha-subunit responses to stimuli in such adenomas are generally parallel with those of the concomitantly produced hormones.
对165例垂体腺瘤患者测定了血清糖蛋白激素α亚基水平。17例患者血清α亚基水平升高(肢端肥大症患者58例中有5例;催乳素瘤患者56例中有6例;无功能腺瘤患者32例中有5例;促肾上腺皮质激素分泌性腺瘤患者19例中有1例),其中大多数患者血清促甲状腺激素(TSH)和促性腺激素水平正常。对6例血清α亚基水平升高的催乳素瘤患者静脉注射促甲状腺激素释放激素(TRH,0.5mg)后,仅1例患者血清催乳素(PRL)和α亚基水平升高。4例血清α亚基水平高的肢端肥大症患者接受了TRH;1例患者血清生长激素(GH)和α亚基升高,2例患者无变化,其余1例患者仅血清GH升高。另一方面,口服溴隐亭(5mg)可使2例催乳素瘤患者的血清α亚基和PRL水平持续下降,使1例肢端肥大症患者的血清α亚基和GH水平下降。对3例患者的血清进行葡聚糖凝胶G-100凝胶过滤时,免疫反应性α亚基在单一峰中洗脱,该峰出现在与[125I]TSHα相对应的组分中。伴刀豆球蛋白A(Con A)亲和层析显示,免疫反应性α亚基的主要部分被Con A保留。对1例肢端肥大症患者手术切除的垂体腺瘤进行单层细胞培养研究。培养的腺瘤细胞分泌α亚基和GH均受到TRH的刺激,并受到多巴胺的剂量依赖性抑制。对血清α亚基水平高的催乳素瘤和肢端肥大症患者手术切除的垂体腺瘤进行免疫组织化学检查,发现含α亚基的细胞以及含PRL或GH的细胞。这些结果表明,在相当数量的垂体腺瘤患者中,糖蛋白激素α亚基的分泌发生在糖蛋白激素未同时产生的情况下,并且此类腺瘤中α亚基对刺激的反应通常与同时产生的激素的反应平行。